- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- March 2025
- 179 Pages
Global
From €4727EUR$4,950USD£3,953GBP
- Report
- May 2024
- 182 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- November 2023
- 162 Pages
Global
From €2388EUR$2,500USD£1,997GBP
- Report
- April 2023
- 110 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£759GBP
- Report
- June 2023
- 108 Pages
Global
From €3500EUR$3,926USD£3,029GBP
The Neuroscience Antibodies and Assays market is a subset of the Central Nervous System Drugs market, which focuses on the development of treatments for neurological disorders. Neuroscience Antibodies and Assays are used to detect and measure the presence of specific proteins, enzymes, and other molecules in the brain and spinal cord. These assays are used to diagnose and monitor neurological diseases, as well as to assess the efficacy of potential treatments.
Neuroscience Antibodies and Assays are used in a variety of research and clinical settings, including drug discovery, biomarker development, and clinical diagnostics. They are also used to study the effects of drugs on the brain and spinal cord, as well as to monitor the progression of neurological diseases.
Some companies in the Neuroscience Antibodies and Assays market include Abcam, Bio-Rad, Merck Millipore, Thermo Fisher Scientific, and PerkinElmer. Show Less Read more